ResMed's (ASX:RMD) Chief Financial Officer Brett Sandercock sold 1,000 common shares on the New York Stock Exchange for $215,580 in total, according to a Wednesday filing with the Australian bourse.
Following the sale of shares, Sandercock owns about 146.9 million shares in the company, per the filing.